Novo Nordisk A/S (BVMF:N1VO34)
31.60
-0.01 (-0.03%)
Last updated: Dec 4, 2025, 11:48 AM GMT-3
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of 1.12 trillion as of December 4, 2025. Its market cap has decreased by -56.08% in one year.
Market Cap
1.12T
Enterprise Value
1.17T
Revenue
264.23B
Ranking
n/a
PE Ratio
12.87
Stock Price
31.60
Market Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 7.50B to 1.12T, an increase of 14,809.54%. That is a compound annual growth rate of 18.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 1.12T | -53.27% |
| Dec 30, 2024 | 2.40T | 7.38% |
| Dec 29, 2023 | 2.24T | 39.16% |
| Dec 30, 2022 | 1.61T | 13.12% |
| Dec 30, 2021 | 1.42T | 68.94% |
| Dec 30, 2020 | 842.13B | 53.52% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 102.57B |
| Raia Drogasil | 41.64B |
| Hypera | 16.70B |
| Fleury | 8.77B |
| Odontoprev | 6.42B |
| Diagnósticos da América | 4.35B |
| Empreendimentos Pague Menos | 4.06B |
| Blau Farmacêutica | 2.32B |